Close Menu
Home » iCubate Receives CE Mark for Dx Platform, Bloodstream Infection Assay

iCubate Receives CE Mark for Dx Platform, Bloodstream Infection Assay

Aug 23, 2017
|
staff reporter

NEW YORK (GenomeWeb) – iCubate announced yesterday that it has received CE mark for its first clinical assay, the iC-GPC assay and its platform, the iC-System, used for the rapid diagnosis of pathogenic bacteria associated with bloodstream infection. The CE mark provides an entry for iCubate to begin market integration into the European Union.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Diversity of African Genomes

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

'We Gotta Change These Numbers'

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Science Like a Girl

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

Science Looks at Beneficial Genetic Variants in the Melanesian Population, and More

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Avellino Labs Gets CLIA Certification

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.